Trump administration: Drugmakers that hiked prices may create 'tipping point'
The Trump administration said Monday it is closely watching reports of drug increases. (The White House)
The secretary of HHS had a direct message on Monday for the pharmaceutical companies that have hiked the prices of their products in recent months: The presidentsees you.
Speaking at an event hosted by the 340B Coalition, he alluded to a tweet earlier in the day from the commander-in-chiefspecifically calling out drug giant Pfizer and other drug companies for hiking their prices in recent months.
Join Blue Health Intelligence (BHI) and Midwest Business Group on Health (MBGH) to hear how key descriptive, predictive and prescriptive analytics capabilities can drive new cost and quality insights for health plans, employers and benefit consultants.